These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12550109)

  • 21. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
    Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
    Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris.
    Nockowski P; Szepietowski JC; Ziarkiewicz M; Baran E
    Acta Dermatovenerol Croat; 2004; 12(1):2-6. PubMed ID: 15072741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Janik P
    Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neuroinflammation; 2011 May; 8():47. PubMed ID: 21569455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
    Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
    J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Matrix metalloproteinase-9 (MMP-9) activity in cerebrospinal fluid of amyotrophic lateral sclerosis patients].
    Iłzecka J; Stelmasiak Z; Dobosz B
    Neurol Neurochir Pol; 2001; 35(6):1035-43. PubMed ID: 11987700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
    J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurospecific proteins in cerebrospinal fluid and in the bloodserum of patients with amyotrophic lateral sclerosis].
    Rushkevich YN; Pashkouskaya ID; Likhachev SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5):75-80. PubMed ID: 29927408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report.
    Iłzecka J
    Scand J Clin Lab Invest; 2008; 68(4):348-51. PubMed ID: 17852832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase.
    Niebrój-Dobosz I; Domitrz I; Mickielewicz A
    Folia Neuropathol; 1999; 37(2):107-12. PubMed ID: 10464429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis.
    Iłżecka J
    Clin Biochem; 2011 Jun; 44(8-9):650-3. PubMed ID: 21349256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
    Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
    Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Rentzos M; Rombos A; Nikolaou C; Zoga M; Zouvelou V; Dimitrakopoulos A; Alexakis T; Tsoutsou A; Samakovli A; Michalopoulou M; Evdokimidis I
    Eur Neurol; 2010; 63(5):285-90. PubMed ID: 20407265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.